ARTICLE | Analyst Picks & Changes
Analyst picks & changes
October 25, 1993 7:00 AM UTC
Robert Fine of Nomura Equity Research initiated coverage of Creative BioMolecules Inc. with a "buy." He said CBMI shares have a fair value of $11 and he has a one-year price target of $15. ...